Design Therapeutics, Inc. (DSGN)

Design Therapeutics Statistics

Total Valuation

DSGN has a market cap or net worth of $233.04 million. The enterprise value is $5.22 million.

Market Cap	233.04M
Enterprise Value	5.22M

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025, before market open.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

DSGN has 56.77 million shares outstanding. The number of shares has increased by 0.94% in one year.

Current Share Class	56.77M
Shares Outstanding	56.77M
Shares Change (YoY)	+0.94%
Shares Change (QoQ)	+0.13%
Owned by Insiders (%)	15.54%
Owned by Institutions (%)	41.88%
Float	25.54M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.99
P/TBV Ratio	1.02
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 28.37, with a Debt / Equity ratio of 0.01.

Current Ratio	28.37
Quick Ratio	28.06
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -22.59% and return on invested capital (ROIC) is -17.02%.

Return on Equity (ROE)	-22.59%
Return on Assets (ROA)	-16.56%
Return on Invested Capital (ROIC)	-17.02%
Return on Capital Employed (ROCE)	-29.84%
Revenue Per Employee	n/a
Profits Per Employee	-$1.04M
Employee Count	54
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -18.60% in the last 52 weeks. The beta is 1.57, so DSGN's price volatility has been higher than the market average.

Beta (5Y)	1.57
52-Week Price Change	-18.60%
50-Day Moving Average	3.89
200-Day Moving Average	4.69
Relative Strength Index (RSI)	53.41
Average Volume (20 Days)	90,563

Short Selling Information

The latest short interest is 3.53 million, so 6.22% of the outstanding shares have been sold short.

Short Interest	3.53M
Short Previous Month	3.62M
Short % of Shares Out	6.22%
Short % of Float	13.83%
Short Ratio (days to cover)	34.28

Income Statement

Revenue	n/a
Gross Profit	-49.93M
Operating Income	-68.40M
Pretax Income	-50.53M
Net Income	-56.20M
EBITDA	-67.79M
EBIT	-68.40M
Earnings Per Share (EPS)	-$0.99

Balance Sheet

The company has $229.67 million in cash and $2.14 million in debt, giving a net cash position of $227.53 million or $4.01 per share.

Cash & Cash Equivalents	229.67M
Total Debt	2.14M
Net Cash	227.53M
Net Cash Per Share	$4.01
Equity (Book Value)	227.92M
Book Value Per Share	4.01
Working Capital	225.41M

Cash Flow

In the last 12 months, operating cash flow was -$47.46 million and capital expenditures -$217,000, giving a free cash flow of -$47.67 million.

Operating Cash Flow	-47.46M
Capital Expenditures	-217,000
Free Cash Flow	-47.67M
FCF Per Share	-$0.84

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DSGN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.94%
Shareholder Yield	n/a
Earnings Yield	-24.15%
FCF Yield	-20.48%

Analyst Forecast

The average price target for DSGN is $4.00, which is -2.56% lower than the current price. The consensus rating is "Hold".

Price Target	$4.00
Price Target Difference	-2.56%
Analyst Consensus	Hold
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	8.89%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1